We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$330M
Cap. Flow %
8.14%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
1.2 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.2 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
K icon
Kellanova
K
+$269M
2
SRCL icon
Stericycle Inc
SRCL
+$141M
3
MRO icon
Marathon Oil Corporation
MRO
+$108M
4
CHX icon
ChampionX
CHX
+$103M
5
SPR icon
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN icon
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X icon
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PYPL icon
351
PayPal
PYPL
$47.5B
$390K 0.01%
5,000
-5,000
-50% -$334K
2023 Q1
6 quarters
MLYS icon
352
Mineralys Therapeutics
MLYS
$2.07B
$376K 0.01%
31,068
-28,863
-48% -$349K
2023 Q4
3 quarters
NGNE icon
353
Neurogene
NGNE
$528M
$370K 0.01%
8,827
+1,727
+24% +$67K
2024 Q2
1 quarter
CC icon
354
PUT
Chemours
CC
$2.05B
$352K 0.01%
46,900
– –
2024 Q2
1 quarter
AMC icon
355
AMC Entertainment Holdings
AMC
$2.66B
$350K 0.01%
77,028
-840
-1% -$4.19K
2023 Q3
4 quarters
MFA icon
356
MFA Financial
MFA
$695M
$342K 0.01%
26,868
-70,553
-72% -$832K
2024 Q1
2 quarters
KWEB icon
357
KraneShares CSI China Internet ETF
KWEB
$4.54B
$340K 0.01%
+10,000
New +$269K
2024 Q3
0 quarters
ZURA icon
358
Zura Bio
ZURA
$383M
$329K 0.01%
80,912
+7,516
+10% +$28.1K
2024 Q2
1 quarter
PTON icon
359
Peloton Interactive
PTON
$2.25B
$328K 0.01%
70,000
-190,000
-73% -$747K
2024 Q2
1 quarter
CORT icon
360
CALL
Corcept Therapeutics
CORT
$13.1B
$290K 0.01%
+45,000
New +$1.6M
2024 Q3
0 quarters
ASAN icon
361
Asana
ASAN
$2.31B
$290K 0.01%
25,000
-277,500
-92% -$3.66M
2023 Q1
6 quarters
NERV icon
362
Minerva Neurosciences
NERV
$152M
$286K 0.01%
107,256
+7,400
+7% +$21.5K
2023 Q3
4 quarters
NCLH icon
363
PUT
Norwegian Cruise Line
NCLH
$7.15B
$283K 0.01%
233,800
– –
2021 Q2
13 quarters
CHTR icon
364
PUT
Charter Communications
CHTR
$11.8B
$269K 0.01%
8,400
– –
2024 Q1
2 quarters
BABA icon
365
Alibaba
BABA
$277B
$265K 0.01%
+2,500
New +$205K
2024 Q3
0 quarters
TXN icon
366
Texas Instruments
TXN
$259B
$258K 0.01%
+1,250
New +$251K
2024 Q3
0 quarters
CCL icon
367
PUT
Carnival Corporation Ltd
CCL
$35.4B
$256K 0.01%
891,500
+120,000
+16% +$2.03M
2021 Q3
12 quarters
VERU icon
368
Veru
VERU
$41.9M
$254K 0.01%
32,986
+3,064
+10% +$26.4K
2023 Q4
3 quarters
HOG icon
369
PUT
Harley-Davidson
HOG
$2.8B
$241K 0.01%
235,000
+135,000
+135% +$4.89M
2023 Q3
4 quarters
SCYX icon
370
SCYNEXIS
SCYX
$40.6M
$239K 0.01%
20,020
+1,860
+10% +$26.3K
2022 Q2
9 quarters
MPT icon
371
PUT
Medical Properties Trust
MPT
$1.88B
$232K 0.01%
396,500
– –
2024 Q2
1 quarter
NBR icon
372
PUT
Nabors Industries
NBR
$1.23B
$226K 0.01%
19,100
– –
2024 Q1
2 quarters
ABBV icon
373
AbbVie
ABBV
$489B
$226K 0.01%
1,146
-12,049
-91% -$2.25M
2022 Q3
8 quarters
CPRI icon
374
PUT
Capri Holdings
CPRI
$1.7B
$220K 0.01%
12,600
– –
2021 Q2
13 quarters
APLS icon
375
DELISTED
Apellis Pharmaceuticals
APLS
$219K 0.01%
+7,603
New +$282K
2024 Q3
0 quarters
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.